{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:37:03Z","timestamp":1791103023331,"version":"4.1.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple endocrine neoplasia type 1 (MEN1) is an autosomal syndrome caused by mutations in the MEN1 tumor suppressor gene. Whereas the protein product of MEN1, menin, is ubiquitously expressed, somatic loss of the remaining wild-type MEN1 allele results in tumors primarily in parathyroid, pituitary, and endocrine pancreas. To understand the endocrine specificity of the MEN1 syndrome, we evaluated biallelic loss of Men1 by inactivating Men1 in pancreatic progenitor cells using the Cre-lox system. Men1 deletion in progenitor cells that differentiate into exocrine and endocrine pancreas did not affect normal pancreas morphogenesis and development. However, mice having homozygous inactivation of the Men1 in pancreas developed endocrine tumors with no exocrine tumor manifestation, recapitulating phenotypes seen in the MEN1 patients. In the absence of menin, the endocrine pancreas showed increase in cell proliferation, vascularity, and abnormal vascular structures; such changes were lacking in exocrine pancreas. Further analysis revealed that these endocrine manifestations were associated with up-regulation in vascular endothelial growth factor expression in both human and mouse MEN1 pancreatic endocrine tumors. Together, these data suggest the presence of cell-specific factors for menin and a permissive endocrine environment for MEN1 tumorigenesis in endocrine pancreas. Based on our analysis, we propose that menin's ability to maintain cellular and microenvironment integrity might explain the endocrine- restrictive nature of the MEN1 syndrome. [Cancer Res 2009;69(5):1858\u201366]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-3662","type":"journal-article","created":{"date-parts":[[2009,2,11]],"date-time":"2009-02-11T11:35:04Z","timestamp":1234352104000},"page":"1858-1866","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Recapitulation of Pancreatic Neuroendocrine Tumors in Human Multiple Endocrine Neoplasia Type I Syndrome via\n                    <i>Pdx1<\/i>\n                    -Directed Inactivation of\n                    <i>Men1<\/i>"],"prefix":"10.1158","volume":"69","author":[{"given":"H.-C. Jennifer","family":"Shen","sequence":"first","affiliation":[{"name":"1Tumor Angiogenesis Section, Surgery Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"He","sequence":"additional","affiliation":[{"name":"1Tumor Angiogenesis Section, Surgery Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anathea","family":"Powell","sequence":"additional","affiliation":[{"name":"1Tumor Angiogenesis Section, Surgery Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Adem","sequence":"additional","affiliation":[{"name":"1Tumor Angiogenesis Section, Surgery Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Lorang","sequence":"additional","affiliation":[{"name":"1Tumor Angiogenesis Section, Surgery Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Heller","sequence":"additional","affiliation":[{"name":"1Tumor Angiogenesis Section, Surgery Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia C.","family":"Grover","sequence":"additional","affiliation":[{"name":"1Tumor Angiogenesis Section, Surgery Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Ylaya","sequence":"additional","affiliation":[{"name":"2Laboratory of Pathology, National Cancer Institute and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Hewitt","sequence":"additional","affiliation":[{"name":"2Laboratory of Pathology, National Cancer Institute and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Marx","sequence":"additional","affiliation":[{"name":"3Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen M.","family":"Spiegel","sequence":"additional","affiliation":[{"name":"4Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Libutti","sequence":"additional","affiliation":[{"name":"1Tumor Angiogenesis Section, Surgery Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,3,2]]},"reference":[{"key":"2022061701334327500_B1","doi-asserted-by":"crossref","unstructured":"Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science\u20081997; 276: 404\u20137.","DOI":"10.1126\/science.276.5311.404"},{"key":"2022061701334327500_B2","doi-asserted-by":"crossref","unstructured":"Lemmens I, Van de Ven WJ, Kas K, et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet\u20081997; 6: 1177\u201383.","DOI":"10.1093\/hmg\/6.7.1177"},{"key":"2022061701334327500_B3","doi-asserted-by":"crossref","unstructured":"Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA. Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med\u20081998; 129: 484\u201394.","DOI":"10.7326\/0003-4819-129-6-199809150-00011"},{"key":"2022061701334327500_B4","doi-asserted-by":"crossref","unstructured":"Trump D, Farren B, Wooding C, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Qjm\u20081996; 89: 653\u201369.","DOI":"10.1093\/qjmed\/89.9.653"},{"key":"2022061701334327500_B5","doi-asserted-by":"crossref","unstructured":"Stratakis CA, Schussheim DH, Freedman SM, et al. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J Clin Endocrinol Metab\u20082000; 85: 4776\u201380.","DOI":"10.1210\/jc.85.12.4776"},{"key":"2022061701334327500_B6","doi-asserted-by":"crossref","unstructured":"Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A\u20081971; 68: 820\u20133.","DOI":"10.1073\/pnas.68.4.820"},{"key":"2022061701334327500_B7","doi-asserted-by":"crossref","unstructured":"Guru SC, Manickam P, Crabtree JS, Olufemi SE, Agarwal SK, Debelenko LV. Identification and characterization of the multiple endocrine neoplasia type 1 (MEN1) gene. J Intern Med\u20081998; 243: 433\u20139.","DOI":"10.1046\/j.1365-2796.1998.00346.x"},{"key":"2022061701334327500_B8","doi-asserted-by":"crossref","unstructured":"Ludwig L, Schleithoff L, Kessler H, Wagner PK, Boehm BO, Karges W. Loss of wild-type MEN1 gene expression in multiple endocrine neoplasia type 1-associated parathyroid adenoma. Endocr J\u20081999; 46: 539\u201344.","DOI":"10.1507\/endocrj.46.539"},{"key":"2022061701334327500_B9","unstructured":"Valdes N, Alvarez V, Diaz-Cadorniga F, et al. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases. Anticancer Res\u20081998; 18: 2685\u20139."},{"key":"2022061701334327500_B10","doi-asserted-by":"crossref","unstructured":"Heppner C, Kester MB, Agarwal SK, et al. Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet\u20081997; 16: 375\u20138.","DOI":"10.1038\/ng0897-375"},{"key":"2022061701334327500_B11","unstructured":"Wang EH, Ebrahimi SA, Wu AY, Kashefi C, Passaro E, Jr., Sawicki MP. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors. Cancer Res\u20081998; 58: 4417\u201320."},{"key":"2022061701334327500_B12","doi-asserted-by":"crossref","unstructured":"Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat\u20082008; 29: 22\u201332.","DOI":"10.1002\/humu.20605"},{"key":"2022061701334327500_B13","doi-asserted-by":"crossref","unstructured":"Agarwal SK, Kennedy PA, Scacheri PC, et al. Menin molecular interactions: insights into normal functions and tumorigenesis. Horm Metab Res\u20082005; 37: 369\u201374.","DOI":"10.1055\/s-2005-870139"},{"key":"2022061701334327500_B14","doi-asserted-by":"crossref","unstructured":"Balogh K, Racz K, Patocs A, Hunyady L. Menin and its interacting proteins: elucidation of menin function. Trends Endocrinol Metab\u20082006; 17: 357\u201364.","DOI":"10.1016\/j.tem.2006.09.004"},{"key":"2022061701334327500_B15","doi-asserted-by":"crossref","unstructured":"Hughes CM, Rozenblatt-Rosen O, Milne TA, et al. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell\u20082004; 13: 587\u201397.","DOI":"10.1016\/S1097-2765(04)00081-4"},{"key":"2022061701334327500_B16","doi-asserted-by":"crossref","unstructured":"Chen YX, Yan J, Keeshan K, et al. The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proc Natl Acad Sci U S A\u20082006; 103: 1018\u201323.","DOI":"10.1073\/pnas.0510347103"},{"key":"2022061701334327500_B17","doi-asserted-by":"crossref","unstructured":"Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, Cleary ML. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell\u20082005; 123: 207\u201318.","DOI":"10.1016\/j.cell.2005.09.025"},{"key":"2022061701334327500_B18","doi-asserted-by":"crossref","unstructured":"Yokoyama A, Wang Z, Wysocka J, et al. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol\u20082004; 24: 5639\u201349.","DOI":"10.1128\/MCB.24.13.5639-5649.2004"},{"key":"2022061701334327500_B19","doi-asserted-by":"crossref","unstructured":"Karnik SK, Hughes CM, Gu X, et al. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci U S A\u20082005; 102: 14659\u201364.","DOI":"10.1073\/pnas.0503484102"},{"key":"2022061701334327500_B20","doi-asserted-by":"crossref","unstructured":"Karnik SK, Chen H, McLean GW, et al. Menin controls growth of pancreatic \u03b2-cells in pregnant mice and promotes gestational diabetes mellitus. Science\u20082007; 318: 806\u20139.","DOI":"10.1126\/science.1146812"},{"key":"2022061701334327500_B21","doi-asserted-by":"crossref","unstructured":"Bertolino P, Tong WM, Galendo D, Wang ZQ, Zhang CX. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Mol Endocrinol\u20082003; 17: 1880\u201392.","DOI":"10.1210\/me.2003-0154"},{"key":"2022061701334327500_B22","doi-asserted-by":"crossref","unstructured":"Crabtree JS, Scacheri PC, Ward JM, et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A\u20082001; 98: 1118\u201323.","DOI":"10.1073\/pnas.98.3.1118"},{"key":"2022061701334327500_B23","doi-asserted-by":"crossref","unstructured":"Loffler KA, Biondi CA, Gartside M, et al. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1. Int J Cancer\u20082007; 120: 259\u201367.","DOI":"10.1002\/ijc.22288"},{"key":"2022061701334327500_B24","doi-asserted-by":"crossref","unstructured":"Bassett JH, Rashbass P, Harding B, Forbes SA, Pannett AA, Thakker RV. Studies of the murine homolog of the multiple endocrine neoplasia type 1 (MEN1) gene, men1. J Bone Miner Res\u20081999; 14: 3\u201310.","DOI":"10.1359\/jbmr.1999.14.1.3"},{"key":"2022061701334327500_B25","doi-asserted-by":"crossref","unstructured":"Guru SC, Crabtree JS, Brown KD, et al. Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene. Mamm Genome\u20081999; 10: 592\u20136.","DOI":"10.1007\/s003359901051"},{"key":"2022061701334327500_B26","doi-asserted-by":"crossref","unstructured":"Bertolino P, Radovanovic I, Casse H, Aguzzi A, Wang ZQ, Zhang CX. Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs. Mech Dev\u20082003; 120: 549\u201360.","DOI":"10.1016\/S0925-4773(03)00039-X"},{"key":"2022061701334327500_B27","unstructured":"Libutti SK, Crabtree JS, Lorang D, et al. Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. Cancer Res\u20082003; 63: 8022\u20138."},{"key":"2022061701334327500_B28","unstructured":"Bertolino P, Tong WM, Herrera PL, Casse H, Zhang CX, Wang ZQ. Pancreatic \u03b2-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Res\u20082003; 63: 4836\u201341."},{"key":"2022061701334327500_B29","doi-asserted-by":"crossref","unstructured":"Crabtree JS, Scacheri PC, Ward JM, et al. Of mice and MEN1: insulinomas in a conditional mouse knockout. Mol Cell Biol\u20082003; 23: 6075\u201385.","DOI":"10.1128\/MCB.23.17.6075-6085.2003"},{"key":"2022061701334327500_B30","doi-asserted-by":"crossref","unstructured":"Biondi CA, Gartside MG, Waring P, et al. Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues. Mol Cell Biol\u20082004; 24: 3125\u201331.","DOI":"10.1128\/MCB.24.8.3125-3131.2004"},{"key":"2022061701334327500_B31","doi-asserted-by":"crossref","unstructured":"Stewart C, Parente F, Piehl F, et al. Characterization of the mouse Men1 gene and its expression during development. Oncogene\u20081998; 17: 2485\u201393.","DOI":"10.1038\/sj.onc.1202164"},{"key":"2022061701334327500_B32","doi-asserted-by":"crossref","unstructured":"Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development\u20082002; 129: 2447\u201357.","DOI":"10.1242\/dev.129.10.2447"},{"key":"2022061701334327500_B33","doi-asserted-by":"crossref","unstructured":"Thurston G, Baluk P, Hirata A, McDonald DM. Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am J Physiol\u20081996; 271: H2547\u201362.","DOI":"10.1152\/ajpheart.1996.271.6.H2547"},{"key":"2022061701334327500_B34","doi-asserted-by":"crossref","unstructured":"Blansfield JA, Caragacianu D, Alexander HR III, et al. Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy. Clin Cancer Res\u20082008; 14: 270\u201380.","DOI":"10.1158\/1078-0432.CCR-07-1562"},{"key":"2022061701334327500_B35","doi-asserted-by":"crossref","unstructured":"Chow LQ, Eckhardt SG. Sunitinib: from rational design to clinical efficacy. J Clin Oncol\u20082007; 25: 884\u201396.","DOI":"10.1200\/JCO.2006.06.3602"},{"key":"2022061701334327500_B36","doi-asserted-by":"crossref","unstructured":"Schnepp RW, Chen YX, Wang H, et al. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells. Cancer Res\u20082006; 66: 5707\u201315.","DOI":"10.1158\/0008-5472.CAN-05-4518"},{"key":"2022061701334327500_B37","doi-asserted-by":"crossref","unstructured":"Carmeliet P. Angiogenesis in life, disease and medicine. Nature\u20082005; 438: 932\u20136.","DOI":"10.1038\/nature04478"},{"key":"2022061701334327500_B38","doi-asserted-by":"crossref","unstructured":"Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature\u20081989; 339: 58\u201361.","DOI":"10.1038\/339058a0"},{"key":"2022061701334327500_B39","unstructured":"Mendel DB, Laird AD, Xin X, et al. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic\/pharmacodynamic relationship. Clin Cancer Res\u20082003; 9: 327\u201337."},{"key":"2022061701334327500_B40","doi-asserted-by":"crossref","unstructured":"Scacheri PC, Crabtree JS, Kennedy AL, et al. Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1. Mamm Genome\u20082004; 15: 872\u20137.","DOI":"10.1007\/s00335-004-2395-z"},{"key":"2022061701334327500_B41","doi-asserted-by":"crossref","unstructured":"Bai F, Pei XH, Nishikawa T, Smith MD, Xiong Y. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors. Mol Cell Biol\u20082007; 27: 1495\u2013504.","DOI":"10.1128\/MCB.01764-06"},{"key":"2022061701334327500_B42","doi-asserted-by":"crossref","unstructured":"Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol\u20082000; 20: 6147\u201358.","DOI":"10.1128\/MCB.20.16.6147-6158.2000"},{"key":"2022061701334327500_B43","doi-asserted-by":"crossref","unstructured":"Lammert E, Gu G, McLaughlin M, et al. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol\u20082003; 13: 1070\u20134.","DOI":"10.1016\/S0960-9822(03)00378-6"},{"key":"2022061701334327500_B44","doi-asserted-by":"crossref","unstructured":"Jiang FX, Naselli G, Harrison LC. Distinct distribution of laminin and its integrin receptors in the pancreas. J Histochem Cytochem\u20082002; 50: 1625\u201332.","DOI":"10.1177\/002215540205001206"},{"key":"2022061701334327500_B45","doi-asserted-by":"crossref","unstructured":"Nikolova G, Jabs N, Konstantinova I, et al. The vascular basement membrane: a niche for insulin gene expression and \u03b2 cell proliferation. Dev Cell\u20082006; 10: 397\u2013405.","DOI":"10.1016\/j.devcel.2006.01.015"},{"key":"2022061701334327500_B46","doi-asserted-by":"crossref","unstructured":"Korsisaari N, Ross J, Wu X, et al. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1. Clin Cancer Res\u20082008; 14: 249\u201358.","DOI":"10.1158\/1078-0432.CCR-07-1552"},{"key":"2022061701334327500_B47","doi-asserted-by":"crossref","unstructured":"Fabian MA, Biggs WH III, Treiber DK, et al. A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol\u20082005; 23: 329\u201336.","DOI":"10.1038\/nbt1068"},{"key":"2022061701334327500_B48","doi-asserted-by":"crossref","unstructured":"Hanahan D. Heritable formation of pancreatic \u03b2-cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes. Nature\u20081985; 315: 115\u201322.","DOI":"10.1038\/315115a0"},{"key":"2022061701334327500_B49","doi-asserted-by":"crossref","unstructured":"Inoue M, Hager JH, Ferrara N, Gerber HP, Hanahan D. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic \u03b2 cell carcinogenesis. Cancer Cell\u20082002; 1: 193\u2013202.","DOI":"10.1016\/S1535-6108(02)00031-4"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/5\/1858\/2620899\/1858.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/5\/1858\/2620899\/1858.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:12:08Z","timestamp":1655435528000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/5\/1858\/552768\/Recapitulation-of-Pancreatic-Neuroendocrine-Tumors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,1]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,3,2]]},"published-print":{"date-parts":[[2009,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-3662","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1158072.618168","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22379810.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499364","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499364.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22379810","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,1]]}}}